Therapeutic potential of induced and natural FoxP3 + regulatory T cells for the treatment of graft-versus-host disease

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 3, 2012, Pages 183-190

  Prinz, Immo ^a   Koenecke, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bone marrow transplantation; FoxP3 + regulatory T cells; GvHD

Indexed keywords

CALCINEURIN INHIBITOR; FOLIC ACID ANTAGONIST; GAMMA INTERFERON; GLUCOCORTICOID; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; STEROID; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN SPECIFICITY; CD4+ CD25+ T LYMPHOCYTE; CD4+FOXP3+ T LYMPHOCYTE; CELL EXPANSION; CELL SELECTION; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOKINE PRODUCTION; DRUG DOSE ESCALATION; DRUG MECHANISM; EFFECTOR CELL; FOXP3+ REGULATORY T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MOLECULAR STABILITY; NONHUMAN; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; RISK BENEFIT ANALYSIS; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT RESPONSE;

ADOPTIVE TRANSFER; ANIMALS; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84863719101     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0172-3     Document Type: Review

References (83)

1. Arimoto K, Kadowaki N, Ishikawa T et al (2007) FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol 85:154-162 (Pubitemid 46365554)
2. + regulatory T cells. Blood 105:4743-4748 (Pubitemid 40807298)
3. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177:8338-8347 (Pubitemid 44893795)
4. Beres A, Komorowski R, Mihara M et al (2011) Instability of Foxp3 expression limits the ability of induced regulatoryT cells tomitigate graft versus host disease. Clin Cancer Res 17:3969-3983
5. Brunstein CG, Miller JS, Cao Q et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117:1061-1070
6. Cao J, Chen C, Zeng L et al (2010) Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versusleukemia effect after bone marrow transplantation. Leuk Res 34:1374-1382
7. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886 (Pubitemid 38032120)
8. Chen X, Das R, Komorowski R et al (2009) Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 114:891-900
9. Chen C, Cao J, Zeng L et al (2011) Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice. Transpl Proc 43:2041-2048
10. + regulatory T cells. Blood 107:1018-1023 (Pubitemid 43156300)
11. + regulatory T cells: more of the same or a division of labor? Immunity 30:626-635
12. Deeg HJ (2007) How I treat refractory acute GVHD. Blood 109:4119-4126 (Pubitemid 46743372)
13. Deeg HJ, Spitzer TR, Cottler-Fox M et al (1991) Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transpl 7:193-198
14. Di Ianni M, Falzetti F, Carotti A et al (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117:3921-3928
15. Dominguez-Villar M, Baecher-Allan CM, Hafler DA (2011) Identification of T helper type 1-like, Foxp3(+) regulatory T cells in human autoimmune disease. Nat Med 17:673-675
16. Duarte JH, Zelenay S, Bergman ML et al (2009) Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 39:948-955
17. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144-1150 (Pubitemid 37173698)
18. + T cells infiltrate the target tissue in experimental autoimmunity. J Immunol 185:7467-7473
19. + regulatory T cells. Nat Immunol 4:330-336 (Pubitemid 36432314)
20. Gershon RK, Kondo K (1971) Infectious immunological tolerance. Immunology 21:903-914
21. Godfrey WR, Ge YG, Spoden DJ et al (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104:453-461 (Pubitemid 38900028)
22. Golovina TN, Mikheeva T, Suhoski MM et al (2008) CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 181:2855-2868
23. + regulatory T cells promote experimental transplantation tolerance. Blood 109:827-835 (Pubitemid 46105988)
24. Hippen KL, Harker-Murray P, Porter SB et al (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 112:2847-2857
25. Hippen KL, Merkel SC, Schirm DK, et al (2011) Massive ex vivo expansion of human natural regulatory T Cells (Tregs) with minimal loss of in vivo functional activity. Sci Transl Med 3:83ra41
26. Hoffmann P, Ermann J, Edinger M et al (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196:389-399 (Pubitemid 34875667)
27. Hoffmann P, Eder R, Kunz-Schughart LA et al (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells. Blood 104:895-903 (Pubitemid 38970590)
28. + regulatory T cells for clinical trials. Biol Blood Marrow Transpl 12:267-274 (Pubitemid 43273711)
29. + regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 39:1088-1097
30. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061 (Pubitemid 36222930)
31. + regulatory T cells ex vivo. Blood 102:2180-2186 (Pubitemid 37122396)
32. Jiang A, Bloom O, Ono S et al (2007) Disruption of E-cadherinmediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27:610-624 (Pubitemid 47615505)
33. + regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother 29:336-349 (Pubitemid 44297302)
34. Khattar M, Chen W, Stepkowski SM (2009) Expanding and converting regulatory T cells: a horizon for immunotherapy. Arch Immunol Ther Exp 57:199-204
35. + T regulatory cells. Nat Immunol 4:337-342 (Pubitemid 36432315)
36. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168:1080-1086 (Pubitemid 34094471)
37. Koenecke C, Czeloth N, Bubke A et al (2009) Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol 39:3091-3096
38. Kolb HJ (2008) Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 112:4371-4383
39. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 106:1903-1908
40. Koreth J, Matsuoka K, Kim HT et al (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365:2055-2066
41. Kroger N, Zabelina T, Kruger W et al (2002) In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versushost disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors. Bone Marrow Transpl 29:683-689 (Pubitemid 34591312)
42. Levings MK, Sangregorio R, Roncarolo MG (2001) Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295-1302
43. Lin CH, Hunig T (2003) Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 33:626-638 (Pubitemid 36367666)
44. + T cell and FOXP3 in hsot acute graft rejection. Zhonghua Nei Ke Za Zhi 45:835-838
45. + T cells are not decreased in human gastric graft-versus-host disease. Biol Blood Marrow Transpl 17:486-496
46. Magenau JM, Qin X, Tawara I et al (2010) Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-hostdisease. B. Biol Blood Marrow Transpl 16:907-914
47. McMurchy AN, Bushell A, Levings MK et al (2011) Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 23:304-313
48. Mielcarek M, Martin PJ, Leisenring W et al (2003) Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102:756-762 (Pubitemid 36842003)
49. + regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 110:1689-1697 (Pubitemid 47443988)
50. Miura Y, Thoburn CJ, Bright EC et al (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104:2187-2193 (Pubitemid 39297878)
51. Miyara M, Sakaguchi S (2011) Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89:346-351
52. Murai M, Krause P, Cheroutre H et al (2010) Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 3:443-449
53. Nguyen VH, Shashidhar S, Chang DS et al (2008) The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111:945-953
54. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31:772-786
55. Petersdorf EW, Gooley T, Malkki M et al (2007) Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens 69(Suppl 1):25-30 (Pubitemid 46625843)
56. Pidala J, Anasetti C, Jim H (2009) Quality of life after allogeneic hematopoietic cell transplantation. Blood 114:7-19
57. + selected hematopoietic cells - clinical problems and current challenges. Leuk Lymphoma 45:447-453 (Pubitemid 38196026)
58. Putnam AL, Brusko TM, Lee MR et al (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58:652-662
59. Ratanatharathorn V, Nash RA, Przepiorka D et al (1998) Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92:2303-2314 (Pubitemid 28452971)
60. Rubtsov YP, Niec RE, Josefowicz S et al (2010) Stability of the regulatory T cell lineage in vivo. Science 329:1667-1671
61. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
62. Schraven B, Kalinke U (2008) CD28 superagonists: what makes the difference in humans? Immunity 28:591-595 (Pubitemid 351636245)
63. Sela U, Olds P, Park A et al (2011) Dendritic cells induce antigenspecific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med 208:2489-2496
64. + regulatory T cells. Blood 118:2342-2350
65. Socie G, Blazar BR (2009) Acute graft-versus-host disease: from the bench to the bedside. Blood 114:4327-4336
66. + regulatory T cells cultured with rapamycin. J Immunol 178:320-329 (Pubitemid 46033615)
67. Taylor PA, Noelle RJ, Blazar BR (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193:1311-1318
68. Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493-3499 (Pubitemid 34534513)
69. + regulatory T cells allows for their purification from expansion cultures. Blood 113:5125-5133
70. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versusleukemia. J Clin Invest 112:1688-1696 (Pubitemid 38063726)
71. - T regulatory cells. Clin Immunol 133:22-26
72. + regulatory T cells from naive precursors by CD40-activated B cells. Blood 112:2554-2562
73. Ukena SN, Grosse J, Mischak-Weissinger E et al (2011a) Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Ann Hematol 90:213-218
74. Ukena SN, Velaga S, Geffers R et al (2011b) Human regulatory T cells in allogeneic stem cell transplantation. Blood 118:e82-e92
75. Ukena SN, Hopting M, Velaga S et al (2011c) Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity. Exp Hematol 39:1152-1160
76. Wagner JE, Thompson JS, Carter SL et al (2005) Effect of graftversus- host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet 366:733-741 (Pubitemid 41207235)
77. Wang ZD, Feng SZ, Zhou SY et al (2006) Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:1215-1220
78. Wood KJ, Hara M, Kingsley CI et al (2001) Immunoregulatory T-cells can mediate specific unresponsiveness to alloantigens in vivo. Transpl Proc 33:3829-3830 (Pubitemid 34042797)
79. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 198:235-247 (Pubitemid 37009740)
80. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA 103:2758-2763
81. Zhou X, Bailey-Bucktrout SL, Jeker LT et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10:1000-1007
82. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108:1571-1579 (Pubitemid 44316124)
83. + regulatory T cells following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 15:382-388